Regarding the Statement in Pfizer's 10-Q Report Dated May 8th, 2009
[ 2009/05/09 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200915.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. FDA ACCEPTS FOR REVIEW EISAI'S NDA ...
Eisai Co., Ltd. 2010/06/03
2. Impact of the Tohoku district-off the Pa...
Kaken Pharmaceutical Co.,Ltd. 2011/03/15
3. KAKEN to outsource the West Japan Distri...
Kaken Pharmaceutical Co.,Ltd. 2003/03/24
4. "Fiblast Spray" to Be Launched...
Kaken Pharmaceutical Co.,Ltd. 2002/08/09
5. Mentax to Be Launched in the US as OTC D...
Kaken Pharmaceutical Co.,Ltd. 2002/02/08

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. U.S. SUBSIDIARY H3 BIOMEDICINE INC. UNDE...
2011/01/28

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us